URL details: dupixenthcp.com/update-during-covid-19-pandemic
URL title:
DUPIXENT® (dupilumab) HCP Website
URL description:
DUPIXENT® (dupilumab) is a dual inhibitor of IL-4 and IL-13 signaling and is now approved for 4 indications. Serious adverse reactions may occur. Please see Important Safety Information and full Prescribing Information on website.
URL last crawled:
2022-07-06
URL speed:
0.357 MB/s,
downloaded in 0.200 seconds
We found no external links pointing to this url.